$IMGN ImmunoGen, Inc. Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ImmunoGen, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ImmunoGen, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in ImmunoGen, Inc. for free.
IRS Number: 042726691
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: IMGN
Company Address: 830 WINTER ST WALTHAM 02451
Former name: IMMUNOGEN INC, date of change: 1992-07-03
ImmunoGen, Inc. engages in the discovery and development of antibody-drug conjugates to improve outcomes for cancer patients. Its pipeline includes Mirvetuximab Soravtansine, IMGN632, IMGC936, and IMGN151. The company was founded on March 27, 1981 and is headquartered in Waltham, MA.
Market Capitalization: $205.16M
Prev close: $2.38
Average Daily Volume: 1,922,020
Days Low: $2.30
Year Low: $1.51
Year High: $9.78
ImmunoGen, Inc. Latest Insider Transactions
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 17 2021 | IMGN | ImmunoGen, Inc. | Wallace Richard John | Director | Option Exercise | A | 6.77 | 44,000 | 297,880 | 44,000 | |
| Jun 17 2021 | IMGN | ImmunoGen, Inc. | Wallace Richard John | Director | Option Exercise | A | 0.00 | 15,000 | 0 | 87,326 | |
| Apr 02 2021 | IMGN | ImmunoGen, Inc. | Goldberg Mark Alan | Director | Option Exercise | A | 0.00 | 1,666 | 0 | 109,876 | |
| Apr 02 2021 | IMGN | ImmunoGen, Inc. | MITCHELL DEAN J | Director | Option Exercise | A | 0.00 | 1,666 | 0 | 93,774 | |
| Feb 09 2021 | IMGN | ImmunoGen, Inc. | Enyedy Mark J | Chief Executive Off ... | Option Exercise | A | 7.69 | 925,000 | 7,113,250 | 925,000 | |
| Feb 09 2021 | IMGN | ImmunoGen, Inc. | Enyedy Mark J | Chief Executive Off ... | Gift | G | 0.00 | 10,000 | 0 | 429,017 | 439 K to 429 K (-2.28 %) |
| Feb 09 2021 | IMGN | ImmunoGen, Inc. | ALTSCHULLER Susan | SVP and CFO | Option Exercise | A | 7.69 | 163,798 | 1,259,607 | 163,798 | |
| Feb 09 2021 | IMGN | ImmunoGen, Inc. | Wingrove Theresa | SVP of Regulatory A ... | Option Exercise | A | 7.69 | 121,905 | 937,449 | 121,905 | |
| Feb 09 2021 | IMGN | ImmunoGen, Inc. | Coen Stacy Ann | Chief Business Offi ... | Option Exercise | A | 7.69 | 185,016 | 1,422,773 | 185,016 | |
| Feb 09 2021 | IMGN | ImmunoGen, Inc. | Lentini Renee | V.P.-Fin., Prin. Ac ... | Option Exercise | A | 7.69 | 80,800 | 621,352 | 80,800 | |
| Feb 09 2021 | IMGN | ImmunoGen, Inc. | Berkenblit Anna | SVP & Chief Medical ... | Option Exercise | A | 7.69 | 282,019 | 2,168,726 | 282,019 | |
| Jan 11 2021 | IMGN | ImmunoGen, Inc. | Lentini Renee | V.P.-Fin., Prin. Ac ... | Option Exercise | A | 6.98 | 40,400 | 281,992 | 40,400 | |
| Jan 11 2021 | IMGN | ImmunoGen, Inc. | Lentini Renee | V.P.-Fin., Prin. Ac ... | Option Exercise | A | 6.98 | 40,400 | 281,992 | 40,400 | |
| Jan 05 2021 | IMGN | ImmunoGen, Inc. | Wingrove Theresa | VP of Regulatory Af ... | Grant | A | 4.04 | 2,659 | 10,742 | 75,750 | 73.1 K to 75.8 K (+3.64 %) |
| Jan 05 2021 | IMGN | ImmunoGen, Inc. | FOSTER DAVID G | V.P.-Fin., Prin. Ac ... | Grant | A | 4.04 | 362 | 1,462 | 38,274 | 37.9 K to 38.3 K (+0.95 %) |